[1] |
Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis[J]. Lancet, 2013, 382(9901): 1329-1340.
|
[2] |
Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia[J]. Eur J Vasc Endovasc Surg, 2019, 58(1s): S1-S109,e33.
|
[3] |
Rosenson RS, Brewer HB Jr, Ansell BJ, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease[J]. Nat Rev Cardiol, 2016, 13(1): 48-60.
|
[4] |
Poznyak A, Grechko AV, Poggio P, et al. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation[J]. Int J Mol Sci, 2020, 21(5): 1835.
|
[5] |
Gratchev A, Sobenin I, Orekhov A, et al. Monocytes as a diagnostic marker of cardiovascular diseases[J]. Immunobiology, 2012, 217(5): 476-482.
|
[6] |
Shah AD, Denaxas S, Nicholas O, et al. Neutrophil counts and initial presentation of 12 cardiovascular diseases: a CALIBER cohort study[J]. J Am Coll Cardiol, 2017, 69(9): 1160-1169.
|
[7] |
Fernández-Ruiz I. Neutrophil-driven SMC death destabilizes atherosclerotic plaques[J]. Nat Rev Cardiol, 2019, 16(8): 455.
|
[8] |
Biscetti F, Bonadia N, Santini F, et al. Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects[J]. Cardiovasc Diabetol, 2019, 18(1): 5.
|
[9] |
Massberg S, Brand K, Grüner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation[J].J Exp Med, 2002, 196(7): 887-896.
|
[10] |
Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis[J]. J Clin Invest, 2005, 115(12): 3378-3384.
|
[11] |
Badimon L, Vilahur G. LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos[J]. Ann N Y Acad Sci, 2012, 1254: 18-32.
|
[12] |
Zhao S, Tang J, Yu S, et al. Monocyte to high-density lipoprotein ratio presents a linear association with atherosclerosis and nonlinear association with arteriosclerosis in elderly Chinese population: the Northern Shanghai Study[J]. Nutr Metab Cardiovasc Dis, 2023, 33(3): 577-583.
|
[13] |
Bath J, Smith JB, Kruse RL, et al. Neutrophil-lymphocyte ratio predicts disease severity and outcome after lower extremity procedures[J]. J Vasc Surg, 2020, 72(2): 622-631.
|
[14] |
Aday AW, Lawler PR, Cook NR, et al. Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence[J]. Circulation, 2018, 138(21): 2330-2341.
|
[15] |
Song Y, Zhao Y, Shu Y, et al. Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: a cross-sectional study[J]. Front Endocrinol (Lausanne), 2023, 14: 1100453.
|
[16] |
Selvaggio S, Abate A, Brugaletta G, et al. Platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio and monocyte-to-HDL cholesterol ratio as markers of peripheral artery disease in elderly patients[J]. Int J Mol Med, 2020, 46(3): 1210-1216.
|
[17] |
Gao JW, Hao QY, Gao M, et al. Triglyceride-glucose index in the development of peripheral artery disease: findings from the atherosclerosis risk in communities(ARIC) study[J]. Cardiovasc Diabetol, 2021, 20(1): 126.
|
[18] |
Zhou Y, Wang L, Jia L, et al. The monocyte to high-density lipoprotein cholesterol ratio in the prediction for atherosclerosis: a retrospective study in adult chinese participants[J]. Lipids, 2021, 56(1): 69-80.
|
[19] |
Celebi S, Berkalp B, Amasyali B. The association between thrombotic and inflammatory biomarkers and lower-extremity peripheral artery disease[J]. Int Wound J, 2020, 17(5): 1346-1355.
|
[20] |
Santoro L, Ferraro PM, Nesci A, et al. Neutrophil-to-lymphocyte ratio but not monocyte-to-HDL cholesterol ratio nor platelet-to-lymphocyte ratio correlates with early stages of lower extremity arterial disease: an ultrasonographic study[J]. Eur Rev Med Pharmacol Sci, 2021, 25(9): 3453-3459.
|
[21] |
Agarwal R, Aurora RG, Siswanto BB, et al. The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease[J]. Coron Artery Dis, 2022, 33(2): 137-143.
|
[22] |
Wang Z, Sheng L, Gu H, et al. Neutrophil-to-lymphocyte ratio predicts restenosis after drug-coated balloon therapy for femoropopliteal artery lesions: a retrospective study[J]. Front Cardiovasc Med, 2022, 9: 868656.
|
[23] |
Mesut E, Cihan A, Orhan G. Is it possible to predict the complexity of peripheral artery disease with atherogenic index?[J]. Vascular, 2020, 28(5): 513-519.
|
[24] |
Lee S, Hoberstorfer T, Wadowski PP, et al. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios predict target vessel restenosis after infrainguinal angioplasty with stent implantation[J]. J Clin Med, 2020, 9(6):1729.
|
[25] |
Russu E, Mureșan AV, Arbănași EM, et al. The predictive role of nlr and plr in outcome and patency of lower limb revascularization in patients with femoropopliteal disease[J]. J Clin Med, 2022, 11(9): 2620.
|
[26] |
Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp[J]. J Clin Endocrinol Metab, 2010, 95(7): 3347-3351.
|
[27] |
Duran Karaduman B, Ayhan H, Keleş T, et al. The triglyceride-glucose index predicts peripheral artery disease complexity[J]. Turk J Med Sci, 2020, 50(5): 1217-1222.
|
[28] |
Liu Y, Chang L, Wu M, et al. Triglyceride glucose index was associated with the risk of peripheral artery disease[J]. Angiology, 2022, 73(7): 655-659.
|
[29] |
Pala AA, Urcun YS. Relationship of triglyceride-glucose index with chronic limb-threatening ischemia in lower extremity peripheral artery disease[J]. Vascular, 2022, 30(3): 455-462.
|